Physician profile
Thomas Madaelil
NPI 1144513177
$2,354.69
in general payments reported to CMS, 2019-2025
12 companies · $509 in 2025
The $509 reported for 2025 was more than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $196 · 2021: $238 · 2022: $477 · 2023: $324 · 2024: $380 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,212.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Balt USA, LLC | $599.88 | 2021-2025 | Optima Coil System, Carrier Delivery Catheter, Raptor Aspiration Catheter |
| Depuy Synthes Sales INC. | $441.49 | 2020-2025 | Cerepak Uniform, Cerebase, Embotrap |
| Stryker Corporation | $431.78 | 2020-2025 | Surpass Evolve, Broadway 8, Evolve |
| Microvention, INC. | $396.44 | 2019-2024 | Eric Retrieval Device, Stent, Web Aneurysm Embolization System |
| Medtronic, INC. | $196.26 | 2022-2024 | Pipeline |
| Phenox INC. | $66.17 | 2022 | |
| Viz.Ai, INC. | $52.56 | 2022 | |
| Cardiva Medical, INC. | $43.63 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $39.24 | 2021-2022 | |
| Medtronic USA, INC. | $34.60 | 2019 | |
| Imperative Care, INC | $29.31 | 2022 | |
| Penumbra, INC. | $23.33 | 2023 | Red 72 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Madaelil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.